An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Conflict of Interest Disclosures: Dr Aggarwal reported receiving grants from Bristol Myers Squibb-Pfizer alliance outside the submitted work; and serving as a consultant for Lexicon Pharmaceuticals; and being involved in research with Novartis (unpaid) outside this submitted work. Dr Vaduganathan reported receiving grant support, serving on the speakers bureau and advisor boards of American Regent, Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, Bristol Myers Squibb, Boehringer Ingelheim, Chiesi, Cytokinetics, Lexicon Pharmaceuticals, Merck, Novartis, Novo Nordisk, Pharmacosmos, Reylypsa, Roche Diagnostics, Sanofi, and Tricog Health and serving as a member of trial committees for AstraZeneca, Galmed, Novartis, Bayer AG, Occlutech, and Impulse Dynamics outside the submitted work. No other disclosures were reported.
Figures
Figure.. Temporal Trends of Cardiovascular-Kidney-Metabolic Syndrome Stages…
Figure.. Temporal Trends of Cardiovascular-Kidney-Metabolic Syndrome Stages Among US Adults, 2011-March 2020
Cardiovascular-kidney-metabolic (CKM) stage…
Figure.. Temporal Trends of Cardiovascular-Kidney-Metabolic Syndrome Stages Among US Adults, 2011-March 2020
Cardiovascular-kidney-metabolic (CKM) stage estimates (95% CI whiskers) are presented by the National Health and Nutrition Examination Survey (NHANES) cycle. All estimates are age-adjusted to the 2010 census and are nationally representative of the US adult population 20 years or older by use of NHANES survey weights. P for trend was >.05 for each stage.
Ndumele CE, Rangaswami J, Chow SL, et al. ; American Heart Association . Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606-1635. doi:10.1161/CIR.0000000000001184
-
DOI
-
PubMed
Ostrominski JW, Arnold SV, Butler J, et al. . Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999-2020. JAMA Cardiol. 2023;8(11):1050-1060. doi:10.1001/jamacardio.2023.3241
-
DOI
-
PMC
-
PubMed
Xu JQ, Murphy SL, Kochanek KD, Arias E. Mortality in the United States, 2021. NCHS Data Brief, No. 456. National Center for Health Statistics; 2022. doi:10.15620/cdc:122516
-
DOI
-
PubMed
Khan SS, Matsushita K, Sang Y, et al. ; Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group . Development and validation of the American Heart Association Predicting Risk of Cardiovascular Disease Events (PREVENT) equations. Circulation. 2024;149:430-449. doi:10.1161/CIRCULATIONAHA.123.067626
-
DOI
-
PMC
-
PubMed
He J, Zhu Z, Bundy JD, Dorans KS, Chen J, Hamm LL. Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic status, 1999-2018. JAMA. 2021;326(13):1286-1298. doi:10.1001/jama.2021.15187
-
DOI
-
PMC
-
PubMed